MedTrace Logo

High Versus Low Dose of Caffeine for Apnea of Prematurity

NCT02103777 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2014-04-04

No results posted yet for this study

Summary

The optimum caffeine dose for apnea of prematurity has not been well investigated so the objective of the study is to compare high versus low dose of caffeine citrate to facilitate successful extubation in mechanically ventilated preterm infants.

Conditions

  • Apnea
  • Preterm Infants

Interventions

DRUG

Caffeine citrate

Caffeine will be given by either high dose in Arm 1 or low dose in Arm 2

Sponsors & Collaborators

  • Mansoura University Children Hospital

    lead OTHER

Principal Investigators

  • sameh m abbas, master · Mansoura University Children Hospital

  • nehad a nasef, MD · Mansoura University Children Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
1 Day
Max Age
10 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2013-09-30
Completion
2013-09-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02103777 on ClinicalTrials.gov